Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1981;48:138-148

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, D. A.
Right arrow Articles by Traystman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, D. A.
Right arrow Articles by Traystman, R. J.

Circulation Research, Vol 48, 138-148, Copyright © 1981 by American Heart Association


ARTICLES

Vasoactive intestinal polypeptide and the canine cerebral circulation

DA Wilson, JT O'Neill, SI Said and RJ Traystman

A potential role for cerebrovascular nerves containing vasoactive intestinal polypeptide (VIP) was examined in 24 anesthetized, ventilated dogs. Cerebral blood flow (CBF) was measured by either the cerebral venous outflow or microsphere method. Plasma VIP concentration was measured by radioimmunoassay. Hypercapnia (5% and 10% CO2) and hypoxia (7% O2) produced significant increases in cerebral venous outflow, but had no affect on arterial or cerebral venous VIP concentrations. Measurements of VIP in cerebrospinal fluid (CSF) made during 5% and 8% CO2 breathing also were not different from control values. VIP produced large dose-dependent increases in common carotid artery and temporalis muscle blood flow when injected or infused intraarterially; however, VIP had no effect on total or regional cerebral blood flow (rCBF) within the brain when administered in a similar manner. Unilateral perfusion of the cerebral ventricles with VIP produced significant increases (range: 11-80%) in rCBF. These data are consistent with the possibility that local release of VIP from perivascular nerve endings could affect CBF. The unresponsiveness of canine cerebral vessels to blood-borne VIP may be due to the blood- brain barrier, since VIP dilates cerebral vessels when the barrier is bypassed by intraventricular infusion. These studies do not support the hypothesis that CBF changes induced during hypercapnia or hypoxia are mediated by VIP.


This article has been cited by other articles:


Home page
J. Physiol.Home page
C A Carrington and M J White
Exercise-induced muscle chemoreflex modulation of spontaneous baroreflex sensitivity in man
J. Physiol., November 1, 2001; 536(3): 957 - 962.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
C. R. Cohen, H. D. Allen, J. Spain, G. R. Marx, R. W. Wolfe, and J. S. Harvey
Cardiac Structure and Function of Elite High School Wrestlers
Arch Pediatr Adolesc Med, May 1, 1987; 141(5): 576 - 581.
[Abstract] [PDF]


Home page
ScienceHome page
E. Hohmann, R. Elde, J. Rysavy, S Einzig, and R. Gebhard
Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers
Science, May 16, 1986; 232(4752): 868 - 871.
[Abstract] [PDF]


Home page
ScienceHome page
T. Lee, A Saito, and I Berezin
Vasoactive intestinal polypeptide-like substance: the potential transmitter for cerebral vasodilation
Science, May 25, 1984; 224(4651): 898 - 901.
[Abstract] [PDF]